Varsha Keelara Tanguturi, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Valve Stenosis | 9 | 2024 | 2001 | 1.260 |
Why?
|
Physicians, Women | 2 | 2023 | 508 | 1.010 |
Why?
|
Heart Valve Diseases | 2 | 2023 | 1027 | 0.860 |
Why?
|
Echocardiography | 9 | 2024 | 4989 | 0.830 |
Why?
|
Healthcare Disparities | 3 | 2019 | 3358 | 0.630 |
Why?
|
Cardiology Service, Hospital | 2 | 2020 | 239 | 0.510 |
Why?
|
Hyperlipidemias | 1 | 2019 | 771 | 0.480 |
Why?
|
Mitral Valve Insufficiency | 3 | 2022 | 1400 | 0.480 |
Why?
|
Patient Readmission | 3 | 2020 | 3270 | 0.460 |
Why?
|
Parenting | 1 | 2020 | 701 | 0.460 |
Why?
|
Unnecessary Procedures | 1 | 2017 | 415 | 0.450 |
Why?
|
Physicians | 2 | 2023 | 4591 | 0.440 |
Why?
|
Aortic Valve | 4 | 2024 | 1955 | 0.430 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2020 | 942 | 0.400 |
Why?
|
Burnout, Professional | 1 | 2020 | 704 | 0.380 |
Why?
|
Income | 1 | 2019 | 1877 | 0.370 |
Why?
|
Heart Valve Prosthesis Implantation | 4 | 2024 | 1553 | 0.330 |
Why?
|
Mitral Valve | 1 | 2017 | 1465 | 0.320 |
Why?
|
Poverty | 1 | 2019 | 2698 | 0.300 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3245 | 0.240 |
Why?
|
Athletes | 1 | 2012 | 1137 | 0.230 |
Why?
|
Death, Sudden, Cardiac | 1 | 2012 | 1555 | 0.220 |
Why?
|
Patient Discharge | 1 | 2016 | 3443 | 0.220 |
Why?
|
Internship and Residency | 1 | 2023 | 5880 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3084 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3204 | 0.200 |
Why?
|
Arrhythmias, Cardiac | 1 | 2012 | 2244 | 0.200 |
Why?
|
Pandemics | 1 | 2020 | 8654 | 0.170 |
Why?
|
Myocardial Infarction | 2 | 2020 | 11460 | 0.160 |
Why?
|
Electrocardiography | 1 | 2012 | 6377 | 0.160 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2022 | 353 | 0.160 |
Why?
|
Quality Indicators, Health Care | 2 | 2020 | 1792 | 0.150 |
Why?
|
Guideline Adherence | 2 | 2019 | 2220 | 0.150 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2023 | 851 | 0.150 |
Why?
|
Exercise Test | 2 | 2023 | 2127 | 0.150 |
Why?
|
Mass Screening | 1 | 2012 | 5428 | 0.130 |
Why?
|
Internal Medicine | 1 | 2023 | 1051 | 0.130 |
Why?
|
Quality Improvement | 3 | 2024 | 3801 | 0.130 |
Why?
|
Registries | 3 | 2023 | 8224 | 0.130 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2023 | 1310 | 0.120 |
Why?
|
Risk Factors | 6 | 2020 | 74206 | 0.110 |
Why?
|
Aortic Valve Insufficiency | 1 | 2018 | 576 | 0.110 |
Why?
|
Postoperative Complications | 1 | 2016 | 15631 | 0.110 |
Why?
|
Patient Care | 1 | 2019 | 622 | 0.110 |
Why?
|
Practice Guidelines as Topic | 3 | 2024 | 7390 | 0.110 |
Why?
|
Humans | 25 | 2024 | 761504 | 0.110 |
Why?
|
Hospitals, General | 1 | 2017 | 798 | 0.110 |
Why?
|
Chest Pain | 1 | 2019 | 1091 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2023 | 2118 | 0.100 |
Why?
|
Aged, 80 and over | 5 | 2024 | 58976 | 0.100 |
Why?
|
Program Evaluation | 2 | 2020 | 2495 | 0.100 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15266 | 0.100 |
Why?
|
Male | 12 | 2024 | 360804 | 0.090 |
Why?
|
Self Care | 1 | 2016 | 796 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2024 | 3600 | 0.090 |
Why?
|
Female | 11 | 2024 | 392644 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2024 | 15842 | 0.090 |
Why?
|
United States | 6 | 2023 | 72334 | 0.080 |
Why?
|
Autonomic Nervous System | 1 | 2015 | 703 | 0.080 |
Why?
|
Exercise Tolerance | 1 | 2015 | 836 | 0.080 |
Why?
|
Triage | 1 | 2016 | 986 | 0.080 |
Why?
|
Checklist | 1 | 2016 | 827 | 0.080 |
Why?
|
Middle Aged | 8 | 2024 | 220895 | 0.080 |
Why?
|
Time Factors | 4 | 2020 | 39967 | 0.080 |
Why?
|
Boston | 2 | 2020 | 9326 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2019 | 3466 | 0.070 |
Why?
|
Aged | 6 | 2024 | 169289 | 0.070 |
Why?
|
Clinical Competence | 1 | 2023 | 4792 | 0.070 |
Why?
|
Linear Models | 1 | 2017 | 5871 | 0.070 |
Why?
|
Hodgkin Disease | 1 | 2015 | 1378 | 0.070 |
Why?
|
Insurance Coverage | 1 | 2018 | 1940 | 0.070 |
Why?
|
Risk Assessment | 2 | 2019 | 23995 | 0.070 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2019 | 2155 | 0.070 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2319 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2020 | 5294 | 0.070 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2012 | 1349 | 0.060 |
Why?
|
Cardiology | 1 | 2016 | 1656 | 0.060 |
Why?
|
Ventricular Function, Left | 3 | 2023 | 3879 | 0.060 |
Why?
|
Odds Ratio | 1 | 2017 | 9646 | 0.060 |
Why?
|
Medicaid | 1 | 2018 | 2818 | 0.060 |
Why?
|
Sex Factors | 1 | 2018 | 10552 | 0.060 |
Why?
|
Stroke Volume | 3 | 2023 | 5496 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14605 | 0.060 |
Why?
|
Databases, Factual | 1 | 2018 | 7967 | 0.050 |
Why?
|
Ontario | 1 | 2023 | 398 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2022 | 64680 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12974 | 0.050 |
Why?
|
Age Factors | 1 | 2018 | 18395 | 0.050 |
Why?
|
Emergency Service, Hospital | 2 | 2020 | 7879 | 0.050 |
Why?
|
Algorithms | 2 | 2022 | 14031 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2017 | 4811 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5440 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 11669 | 0.040 |
Why?
|
Cardiac Tamponade | 1 | 2019 | 175 | 0.040 |
Why?
|
Incidence | 1 | 2016 | 21353 | 0.040 |
Why?
|
Pericardial Effusion | 1 | 2019 | 247 | 0.040 |
Why?
|
Adult | 4 | 2019 | 221177 | 0.030 |
Why?
|
Minority Groups | 1 | 2022 | 1203 | 0.030 |
Why?
|
Arthralgia | 1 | 2019 | 461 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2023 | 1162 | 0.030 |
Why?
|
Propensity Score | 1 | 2022 | 1913 | 0.030 |
Why?
|
Disease Management | 1 | 2024 | 2508 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2024 | 80636 | 0.030 |
Why?
|
Protein Denaturation | 1 | 2012 | 242 | 0.020 |
Why?
|
Young Adult | 1 | 2018 | 59243 | 0.020 |
Why?
|
Genes, MHC Class I | 1 | 2012 | 235 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2012 | 465 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2023 | 5492 | 0.020 |
Why?
|
Ovalbumin | 1 | 2012 | 677 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2020 | 2775 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2023 | 14666 | 0.020 |
Why?
|
Protein Folding | 1 | 2012 | 870 | 0.020 |
Why?
|
Endocytosis | 1 | 2012 | 957 | 0.020 |
Why?
|
Weight Loss | 1 | 2019 | 2684 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6766 | 0.020 |
Why?
|
Ligands | 1 | 2012 | 3272 | 0.020 |
Why?
|
Kinetics | 1 | 2012 | 6374 | 0.010 |
Why?
|
Binding Sites | 1 | 2012 | 6055 | 0.010 |
Why?
|
Cell Membrane | 1 | 2012 | 3688 | 0.010 |
Why?
|
Massachusetts | 1 | 2015 | 8830 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 12725 | 0.010 |
Why?
|
Peptides | 1 | 2012 | 4358 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9351 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9469 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2012 | 10194 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 29625 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39106 | 0.010 |
Why?
|
Mice | 1 | 2012 | 81525 | 0.000 |
Why?
|
Animals | 1 | 2012 | 168459 | 0.000 |
Why?
|